top of page
Writer's picturerokadevaishnavi56
May 29, 20233 min read

Cell and Gene Therapy Market Analysis By Industry Share, Merger, Acquisition, Size Estimation, New I

Emergen Research’s latest market research report focuses on the global Cell and Gene Therapy market, and the report provides in-depth analysis of each of its major segments. Cell and Gene Therapy industry projections and qualitative and quantitative assessments have been provided by the report's authors. The SWOT analysis and Porter’s Five Forces Analysis are some of the most important components of this report that provide insight into the highly competitive environment of the industry. A detailed analysis of the global Cell and Gene Therapy market is presented in the report, including North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Aside from revenue growth drivers & restraints, production & consumption patterns, changing consumer preferences, and stringent regulatory standards, this report also examines other key aspects of regional markets.

The global Cell and Gene Therapy Market is expected to reach USD 6,570.0 Million by 2027, according to a new report by Emergen Research. The sanction of cell and gene therapy focused on early chimeric antigen receptor T-cell immunotherapy has provided lucrative opportunities for drug approvals for extended indications. In the near past, T-cell therapies clinical trials witnessed exponential growth, and constant advances in chimeric antigen receptor T cell therapy are considered as the significant drivers for the growth of the market. Further, while gene therapy has been used mainly for the treatment of cancer, it finds growing use in the treatment of numerous uncommon disease for which there is no treatment at present. Product clearance for non-cancer applications signals a change in customer priorities toward other untapped markets.

The study outlines the rapidly evolving and growing market segments along with valuable insights into each element of the industry. The industry has witnessed the entry of several new players, and the report aims to deliver insightful information about their transition and growth in the market. Mergers, acquisitions, partnerships, agreements, product launches, and joint ventures are all outlined in the report.

Key Companies Profiled in the Report are

Spark Therapeutics LLC, Novartis AG, Gilead Sciences Inc., Bluebird Bio, GlaxoSmithKline, Celgene Corporation, Shire PLC, Sangamo Biosciences, Voyager Therapeutics, and Dimension Therapeutics.

The research report offers a comprehensive regional analysis of the market with regards to production and consumption patterns, import/export, market size and share in terms of volume and value, supply and demand dynamics, and presence of prominent players in each market.

Regional Analysis Covers:

  • North America (U.S., Canada)

  • Europe (U.K., Italy, Germany, France, Rest of EU)

  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)

  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Furthermore, the report provides the analytical data in an organized format segmented into charts, tables, graphs, figures, and diagrams. This enables readers to understand the market scenario in an easy and beneficial manner. Moreover, the report aims to impart a prospective outlook and draw an informative conclusion to assist the reader in making lucrative business decisions. The report, in conclusion, provides a detailed analysis of the segments expected to dominate the market, the regional bifurcation, the estimated market size and share, and comprehensive SWOT analysis and Porter’s Five Forces Analysis.

On the basis of type, the market is segmented into

  • Indication Outlook (Revenue, USD Billion; 2017-2027)

    • Acute Lymphoblastic Leukemia (ALL)

    • Inherited Retinal Disease

    • Large B-Cell Lymphoma

    • ADA-SCID

    • Others


  • Vector Type Outlook (Revenue, USD Billion; 2017-2027)

    • Lentivirus

    • AAV

    • Retrovirus & Gammaretrovirus

    • Modified Herpes Simplex Virus

    • Adenovirus

    • Non-Viral Plasmid Vector


  • Regional Outlook (Revenue, USD Billion; 2017-2027)

    • North America

      1. US.

      2. Canada


  • Europe

    1. Germany

    2. UK

    3. France

    4. BENELUX

    5. Rest of Europe


  • Asia Pacific

    1. China

    2. Japan

    3. South Korea

    4. Rest of APAC


  • Latin America

    1. Brazil

    2. Rest of LATAM


  • MEA

    1. Saudi Arabia

    2. UAE

    3. Rest of MEA



Thank you for reading our report. For further queries, please connect with us, and our team will provide you the report best suited to your requirements.

Latest Published Reports by Emergen Research:


About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyses consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

0 views0 comments

Comments

bottom of page